Fabtech Technologies International Ltd. is set to launch its initial public offering (IPO) on September 29, aiming to raise capital to fuel its growth and strengthen operations. The company, engaged in engineering solutions and turnkey project execution for pharmaceutical, biotechnology, and chemical industries, seeks to leverage investor appetite for manufacturing and technology-driven firms. The IPO will provide Fabtech with resources for capacity expansion, working capital, and debt reduction, while also enhancing its visibility in capital markets.